Lab Med Online.  2021 Apr;11(2):145-148. 10.47429/lmo.2021.11.2.145.

First Case Report of Acute Myeloid Leukemia with MN1-ETV6 Rearrangement at Relapse

• Lee JJ
• Cho HE
• Park KS
• Kim YJ
• Cho SY
• Han JJ
• Lee WI
• Park TS

• KMID: 2525807
• DOI: http://doi.org/10.47429/lmo.2021.11.2.145

Abstract

MN1-ETV6 rearrangement is rarely detected in patients with myeloid neoplasms, such as acute myeloid leukemia, myelodysplastic syndrome, and myelodysplastic/myeloproliferative neoplasms. Usually, MN1-ETV6 rearrangement is found at diagnosis. Here, we report the first Korean AML patient with MN1-ETV6 gene rearrangement in a case of relapse exhibiting normal karyotype at early diagnosis.

Keyword

MN1-ETV6; Acute myeloid leukemia; Relapse

Figure

• 

  Fig. 1 G-banded Karyotype analysis of the patient showed 46,XX,t (12;22) (p13;q12). The arrows indicate translocation of chromosomes 12 and 22.

• 

  Fig. 2 (A) Multiplex RT-PCR results showing Master 6 and M6 Split-out E 409-bp band which targeted for ETV6 exon3-MN1 exon2 fusion gene. (B) Sequencing analysis RT-PCR product showing fusion between exon 3 of the ETV6 (pink block) and exon 2 of MN1 (blue block).

Reference

1. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, et al. 2000; The MN1-TEL fusion protein, encoded by the translocation (12;22) (p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol. 20:9281–93. DOI: 10.1128/MCB.20.24.9281-9293.2000. PMID: 11094079. PMCID: PMC102185.

2. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, et al. 1995; Translocation (12; 22)(p13; q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene. 10:1511–9.

3. Shao H, Cen J, Chen S, Qiu H, Pan J. 2018; Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases. Ann Hematol. 97:417–24. DOI: 10.1007/s00277-017-3208-2. PMID: 29273914.

4. Shao H, Yang Q, Gong Y, Bai S, Zhang J, Wang Y, et al. 2019; [Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 36:112–5.

5. Nofrini V, Berchicci L, La Starza R, Gorello P, Di Giacomo D, Arcioni F, et al. 2011; MN1-ETV6 fusion gene arising from MDS with 5q. Leuk Res. 35:e123–6. DOI: 10.1016/j.leukres.2011.03.019. PMID: 21600651.

6. Chen S, Xue Y, Zhu X, Wu Y, Pan J. 2007; Minimally differentiated acute myeloid leukemia with t(12;22)(p13;q11) translocation showing primary multidrug resistance and expressing multiple multidrug-resistant proteins. Acta Haematol. 118:38–41. DOI: 10.1159/000101997. PMID: 17476096.

7. Heim S, Mitelman F, editors. 2015. Cancer cytogenetics: Chromosomal and molecular genetic aberrations of tumor cells. 4th ed. John Wiley & Sons;Hoboken, NJ: DOI: 10.1002/9781118795569.

8. Swerdlow SH, Campo E, et al. 2017. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Inrernational Agency for Research on Cancer;Lyon, France: p. 421.

9. Estey EH. 2018; Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol. 93:1267–91. DOI: 10.1002/ajh.25214. PMID: 30328165.

10. Nakazato H, Shiozaki H, Zhou M, Nakatsu M, Motoji T, Mizoguchi H, et al. 2001; TEL/MN1 fusion in a de novo acute myeloid leukaemia-M2 patient who showed strong resistance to treatment. Br J Haematol. 113:1079–81. DOI: 10.1046/j.1365-2141.2001.02821-5.x. PMID: 11442509.

11. Vieira L, Marques B, Ambrósio AP, Chumbo M, Reis AB, Junior EC, et al. 2000; TEL and MN1 fusion in myelodysplastic syndrome: new evidence for a therapy-related event. Br J Haematol. 110:238–9. DOI: 10.1046/j.1365-2141.2000.02072-4.x. PMID: 10931009.

12. Wang T, Chen X, Hui S, Ni J, Yin Y, Cao W, et al. 2020; Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22) (p13;q12). Cancer Gene Ther. 1–9. DOI: 10.1038/s41417-019-0159-x. PMID: 31902945. PMCID: PMC7661342.

13. Kim IS, Lee JY, Kong SY, Lee ST, Huh J, Nam MH, et al. 2020; Revision of laboratory testing guidelines for initial diagnosis of hematologic neoplasms. Lab Med Online. 10:10–24. DOI: 10.3343/lmo.2020.10.1.10.